Skip to main content
. 2021 Apr 12;16(4):e0249179. doi: 10.1371/journal.pone.0249179

Fig 5. The in vitro dissolution profile of larazotide acetate (LA) of the delayed release formulation.

Fig 5

The in vitro dissolution data predicts the delayed release formulation of LA will begin releasing in the mid duodenum and complete release in the proximal jejunum. SGF: simulated gastric fluid, SIF: simulated intestinal fluid. Samples 1–6 were replicated and included 1 mg of LA respectively.